Skip to content

Author

Hao Li

We have 2 of 8 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Advances in understanding the tumor microenvironment of neuroendocrine prostate cancer

Longitudinal biopsies, spatial multi-omics, humanized models and biomarker-defined trials are needed to distinguish causal vulnerabilities from correlates of treatment-emergent lineage transition.

Nan Yao, Qi-Xing Yang, Peng-Kang Chang et al. · 0 citations
Open access Jul 2026

FOXA2 suppresses ESCC proliferation and metastasis by inhibiting PSMB9 expression, thereby attenuating proteasome activity

RNA-Seq analysis identified PSMB9 as a key downstream target, indicating that FOXA2 attenuates proteasome activity by suppressing PSMB9 expression, highlighting its critical role in ESCC progression and its potential as a therapeutic target.

Wen-Qiang Xia, Ning Li, Chun-Xia Gong et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.